Question follow-through · 95621
Drugs and Medical Equipment: Prescriptions
To ask the Secretary of State for Health and Social Care, when he expects to complete his review of stakeholder feedback submitted in April 2025 on the Part IX re-categorisation process for Waves 1 to 4, and when updates will be shared with the Drug Tarif
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 1 Dec 2025
- Target answer date
- 3 Dec 2025
- Answer
- 5 Dec 2025 · 4 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Hospices: Finance · 12 Jan 2026
- Sodium Valproate: Compensation · 20 Jan 2026
- Sodium Valproate: Compensation · 20 Jan 2026
- Sodium Valproate: Compensation · 20 Jan 2026
- Sodium Valproate: Compensation · 20 Jan 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
1 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, when he expects to complete his review of stakeholder feedback submitted in April 2025 on the Part IX re-categorisation process for Waves 1 to 4, and when updates will be shared with the Drug Tarif
3 Dec 2025
Target answer date
Date supplied by the official written-questions record.
5 Dec 2025
Answer published
The final draft, version 1.2, of the Part IX Drug Tariff (Med Tech in the community) wave one categorisation was developed in collaboration with an Expert Reference Group and updated in line with stakeholder feedback over four iterations. The final versio...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Hospices: Finance
12 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to provide emergency day-to-day funding to hospices; and whether he will commit to releasing (a) £100 million in emergency funding now and (b) a further £100 million in Apri
Sodium Valproate: Compensation
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the feasibility of establishing a dedicated, no-fault compensation scheme for individuals harmed by sodium valproate exposure, in the context of the recom
Sodium Valproate: Compensation
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department has taken since 2020 to implement the IMMDS Review recommendations on redress for those harmed by sodium valproate; and if he will publish a timetable for delivery.
Sodium Valproate: Compensation
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has estimated the lifetime public cost of not compensating individuals with complex disabilities caused by sodium valproate exposure, including costs to the NHS, social care
Sodium Valproate: Compensation
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether interim compensation payments have been considered for families involved in the first ten claims of the FAC litigation concerning sodium valproate.
Sodium Valproate: Health Services
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment has been made of whether NHS care pathways are adequate for individuals harmed by sodium valproate that require lifelong, multidisciplinary care.
Sodium Valproate: Health Services
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether NHS England plans to commission specialist multidisciplinary services for people affected by sodium valproate exposure, including care coordination, to help reduce emergency admissions and
Sodium Valproate: Health Services
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what guidance exists for Integrated Care Boards on supporting individuals with complex, medicine-induced disabilities arising from sodium valproate.
Sodium Valproate: Health Services
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what data NHS England holds on emergency admissions, emergency care and levels of unmet need among individuals harmed by sodium valproate.
Sodium Valproate: Health Education
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment has been made of the MHRA’s effectiveness at communicating known risks of sodium valproate, particularly in pregnancy, prior to 2018.
Sodium Valproate: Side Effects
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, how many Yellow Card reports relating to harm from sodium valproate, including prenatal exposure, have been received since 2000; and what regulatory action followed.
Sodium Valproate: Health Services
20 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate.